ABCA13 overexpression is associated with the malignant progression in PCa and glioblastoma, and it is also a marker of poor survival in metastatic ovarian serous carcinoma (Hirschmann-Jax et al., 2004; Nymoen et al., 2015; Dréan et al., 2018). The gene discussed is ABCA13; the disease is glioblastoma.